TTop stories Read More Eli Lilly takes aim at illicit market for its experimental weight-loss drugAugust 12, 2026 Eli Lilly said Wednesday it is suing six companies selling versions of its experimental weight-loss drug retatrutide, calling…
TTop stories Read More Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive AdvertisingJuly 21, 2026 Topline Ozempic drugmaker Novo Nordisk sued rival GLP-1 manufacturer Eli Lilly in federal court Tuesday, accusing the company…
TTop stories Read More Eli Lilly to buy psychedelic drugmaker AtaiBeckley for up to $3.8 billion in bet on depression therapyJuly 16, 2026 What happened: AtaiBeckley (ATAI) stock jumped 30% pre-market Thursday after Eli Lilly (LLY) said it would acquire the…
TTop stories Read More What to know about Medicare’s $50 GLP-1 programJuly 1, 2026 NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper…
TTop stories Read More Senator asks RFK Jr. if Eli Lilly’s mystery retatrutide patient is TrumpJune 25, 2026 Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
TTop stories Read More White House Denies Trump Was Given Exclusive Weight Loss DrugJune 23, 2026 Topline The White House aggressively denied inquiries questioning whether President Donald Trump received exclusive access to an Eli…
TTop stories Read More Eli Lilly gave mysterious access to weight loss drug to 79-year-old patientJune 23, 2026 Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
TTop stories Read More Eli Lilly: Single-shot gene therapy lowered cholesterol in early studyMay 25, 2026 Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in…
TTop stories Read More Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous rideApril 20, 2026 Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
HHeadlines Read More Trump unveils 100% tariff that could hit some patented drugs this yearApril 3, 2026 NEW YORK (AP) — President Donald Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs…
TTop stories Read More Eli Lilly’s obesity pill approved by FDA, setting up competition with Novo NordiskApril 2, 2026 Eli Lilly’s obesity pill was approved by the Food and Drug Administration on Wednesday, setting it up for…
TTop stories Read More The Dow surges more than 1,100 points as Wall Street soars to its best day since last springMarch 31, 2026 NEW YORK (AP) — U.S. stocks surged to their best day since last spring, and the Dow Jones…